Cargando…
Fingolimod Potentiates the Antifungal Activity of Amphotericin B
Candida albicans (C. albicans) is an opportunistic human fungal pathogen that can cause severe infection in clinic. Its incidence and mortality rate has been increasing rapidly. Amphotericin B (AMB), the clinical golden standard antifungal agent, has severe side effects that limit its clinical appli...
Autores principales: | Wei, Lu-Qi, Tan, Jing-Cong, Wang, Yue, Mei, Yi-Kun, Xue, Jia-Yu, Tian, Lei, Song, Ke-Yu, Han, Lu, Cui, Ying-Chao, Peng, Yi-Bing, Li, Jing-Quan, Liu, Ning-Ning, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102868/ https://www.ncbi.nlm.nih.gov/pubmed/33968796 http://dx.doi.org/10.3389/fcimb.2021.627917 |
Ejemplares similares
-
Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study
por: Rombauts, Alexander, et al.
Publicado: (2023) -
Repurposing non-antifungal drugs auranofin and pentamidine in combination as fungistatic antifungal agents against C. albicans
por: Lin, Jiaying, et al.
Publicado: (2022) -
Antifungal Activity of Coumarin Against Candida albicans Is Related to Apoptosis
por: Jia, Chang, et al.
Publicado: (2019) -
Amphotericin B colloidal dispersion: an effective drug for the treatment of mucormycosis in China
por: Liu, Juntao, et al.
Publicado: (2023) -
In vitro anti-Leishmania activity of triclabendazole and its synergic effect with amphotericin B
por: Borges, Beatriz Santana, et al.
Publicado: (2023)